Multimedia

A short film tells the story of Khalifa, a nurse in Ghana who contracted typhoid. She takes one drug and then another—each more expensive than the last—but still she isn’t well. The film uses expert interviews and animation to explain why drug resistance threatens us all—and what we can do about it.

After months of study, work, negotiation and anticipation, the Obama administration has announced its development policy. What’s new here and what are the chances of implementation? To find out, I chatted with Connie Veillette, who has recently joined the Center for Global Development as director of our Rethinking U.S. Foreign Assistance program. Connie comes to us from Capitol Hill, where she spent many years with the Congressional Research Service and worked most recently as a senior professional staff member on the Senate Foreign Relations Committee minority staff, specializing in U.S. foreign assistance and USAID.

CGD senior policy analyst Molly Kinder interview on Al Jazeera English on the U.S. humanitarian response to the floods in Pakistan.

Many developing countries have found that large deposits of oil or other natural resources are more a curse than a blessing. My guest on this week's Wonkcast is Alan Gelb, a senior fellow at the Center for Global Development. Together with co-author Sina Grassman, Alan has written a paper that explores the options facing developing countries with abundant natural resources and draws on historical evidence to recommend best practices for dodging the 'resource curse.'

We begin with a discussion of that curse. Alan explains the various problems that accompany oil revenues. Most obviously, that money is easy to misdirect and can often end up fueling corruption. But even for honest and well-intentioned leaders, oil money still presents special headaches. The extreme volatility of oil prices, which can vary by hundreds of percent from one year to the next, make it exceedingly difficult to plan national budgets. The trick is to stock away money in boom oil years to smooth spending in bust years—not easy even when small surpluses are involved. "Clearly you've got to save," Alan explains. But to flatten the boom-bust revenue cycle, "the typical producer may have to save an equivalent of its whole GDP."

Which countries are leading the pack on achieving the Millennium Development Goals? My guest this week is CGD research fellow Ben Leo. In a new working paper, Ben lays out an index for measuring country-level progress towards the MDGs. His paper, the first to offer comparative country-level rankings of progress towards key MDG-related indicators, finds some surprising trailblazers. Who knew that Honduras would come out on top!?

As the UN prepares for the MDG Review Summit next month, the conventional wisdom is that the global progress has been adequate—mostly because of China’s huge size and rapid poverty reduction—but that Africa lags sadly behind. Ben says that this view is overly simplistic, if not just plain wrong. Africa accounts for four of the fifteen countries ranked as “trailblazers,” on track to reach at least half of the examined MDG indicators by the 2015 target year (they are: Burkina Faso, Ethiopia, Ghana, Malawi, and Uganda). Notwithstanding that the MDGs are wildly over ambitious given historical rates of progress (see here and here), Ben finds that low-income countries have made as much progress as middle-income countries. And some countries that we might expect to see on the trailblazer list, such as Tanzania, have performed poorly.

Even as the cost of treating HIV/AIDS has fallen dramatically, the number of people newly infected has remained high. What can be done to reverse this trend and finally defeat this disease? This week on the Wonkcast, I’m joined by Mead Over, a senior fellow here at the Center for Global Development and perhaps the world’s leading expert on the economics of HIV/AIDS. He has recently published two major essays, which introduce the concept of the “AIDS transition”—the point in time where the number of people living with the disease begins to fall. He argues persuasively that to reach this point, international donors must greatly strengthen incentives for effective prevention.

Fueled by charitable giving, more and more medical research is focusing on treating and curing thus-far neglected diseases. Is the regulatory framework ready? My guest this week is Tom Bollyky, a visiting fellow here at the Center for Global Development. Tom is a lawyer by training, and is currently working on the important legal and regulatory issues surrounding clinical trials for medicines to treat neglected diseases.

For those unfamiliar with the scale of the problem, Tom gives a quick introduction to what neglected diseases are. Common diseases like malaria and tuberculosis and less common diseases like dengue fever and hookworm together afflict more than one billion people worldwide. Yet, because they’re not big problems in high income countries, very little research has gone towards finding cures for them.

Leaders of the world’s largest and richest countries met over the weekend in Ontario, Canada. What did they accomplish? This week on the Wonkcast, I’m joined by two guests: CGD Senior Fellow Liliana Rojas-Suarez and Director of Policy Outreach Sarah Jane Staats. We examine the statements released by the two groups—looking specifically at what they have to say about several key policy areas for global development.

Listen to the Wonkcast to hear our conversation. Among other topics, we discuss:

• What President Obama’s G8 announcement on his administration’s development strategy means for the U.S. aid reform agenda.
• The significance of the G20’s release of a set of principles for financial inclusion.
• How the headline issues of financial stability and regulation might affect emerging countries.
• What was said (and wasn’t said) in Toronto on expanding trade, especially for the world’s least developed countries.
• What role an announced G20 Working Group on development might play in the run-up to the next G20 summit this fall in Seoul, South Korea.